Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05624398 · ClinicalTrials.gov registry record · NA

Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery

A NA study of Cataract and Glaucoma Open-Angle, sponsored by Vold Vision P.L.L.C.

Recruiting
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT05624398 is a NA study of Cataract and Glaucoma Open-Angle that is actively recruiting participants, run by Vold Vision P.L.L.C. The registered enrollment target is 25 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05624398, a NA study of Cataract and Glaucoma Open-Angle, is actively recruiting participants, sponsored by Vold Vision P.L.L.C.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

This study is designed to determine how well patients with glaucoma can see following cataract surgery with a special type of lens called an extended-depth-of-focus (EDOF) lens. This lens is intended to reduced the patients need for glasses following cataract surgery. Patients will also undergo a minimally invasive type of glaucoma surgery using a special type of stent to reduce eye pressure, with the goal of better glaucoma control and the reduction in the need for medications to control eye pressure.

Interventions

  • DEVICE Vivity IOL

Study Locations (1)

Arkansas

  • Vold Vision P.L.L.C. - Fayetteville

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2022-12-07
Est. Completion 2025-05-01
Phase NA

Sponsor

Vold Vision P.L.L.C

2 total trials

What the Registry Record Tells You About NCT05624398

The ClinicalTrials.gov registry entry for NCT05624398 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (89% lower). The listed sponsor is Vold Vision P.L.L.C, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which Vivity IOL is the first listed.

NCT05624398 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.

Frequently Asked Questions

What is clinical trial NCT05624398 about?

NCT05624398 is a clinical study titled "Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery". This study is designed to determine how well patients with glaucoma can see following cataract surgery with a special type of lens called an extended-depth-of-focus (EDOF) lens. This lens is intended to reduced the patients need for glasses following cataract surgery. Patients will also undergo a mi...

What is the current status of trial NCT05624398?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2022-12-07. Estimated completion is 2025-05-01.

What conditions does trial NCT05624398 study?

This clinical trial studies the following conditions: Cataract, Glaucoma Open-Angle.

What interventions are being tested in trial NCT05624398?

The interventions under investigation include: Vivity IOL (DEVICE).

Who is sponsoring clinical trial NCT05624398?

This trial is sponsored by Vold Vision P.L.L.C, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05624398 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.